Why the study?
Do non-invasive parameters predict short- and long-term survival in patients with dilated cardiomyopathy?
Do non-invasive parameters predict short- and long-term survival in patients with dilated cardiomyopathy?
Increased mean ventricular wall thickness and hypertrophy-dilation index on M-mode echocardiography predict survival greater than one year in patients with dilated cardiomyopathy.
Answers are grounded in this paper and cite their sources.
These M-mode parameters were associated with >1-year survival; leaves open their value for risk stratification in dilated cardiomyopathy.
Dilated cardiomyopathy (DCM) carries a poor prognosis. This study examined the non-invasive parameters that may be predictive of survival in two groups of patients, short-term survivors who died within one year of onset of symptoms (Group I, 6 patients) and long-term survivors who survived greater than one year of presentation (Group II, 16 patients). The M-mode echocardiogram (E), resting radionuclide ventricular function study (RNA) and electrocardiogram (ECG) were reviewed for factors that would differentiate between Group I and II. The E mean ventricular wall thickness in Group I was 0.6 cm and Group II 0.9 cm (p less than 0.05), a hypertrophy-dilation index (mean thickness/LVDd) was 0.09 for Group I and 0.12 for Group II (p less than 0.05). There was no significant difference between Groups I and II in LVDd by E, RNA, LV ejection fraction, ECG (LVH, ventricular ectopy, conduction abnormalities). Thus, the finding of a mean ventricular wall thickness of 0.9 cm and a hypertrophy-dilation index of greater than 0.10 by E was predictive of survival longer than one year. The ECG and RNA LV ejection fraction did not predict outcome.
No takes yet. Share an insight, caveat, or question.
José Missri (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: